Lyra Therapeutics Merges with HealthBeacon Subsidiary, Delists from Nasdaq
Ticker: LYRA · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1327273
| Field | Detail |
|---|---|
| Company | Lyra Therapeutics, INC. (LYRA) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: merger, acquisition, delisting, private-company
TL;DR
Lyra Therapeutics is officially private after merging with HealthBeacon's subsidiary; Nasdaq delisting effective.
AI Summary
On June 13, 2025, Lyra Therapeutics, Inc. announced the closing of its previously disclosed merger with a subsidiary of HealthBeacon Ltd. The transaction was approved by Lyra's stockholders on June 12, 2025. As a result of the merger, Lyra Therapeutics, Inc. will cease to be a publicly traded company, and its common stock will no longer be listed on the Nasdaq Capital Market.
Why It Matters
This 8-K filing signifies the end of Lyra Therapeutics' journey as an independent, publicly traded entity, transitioning into a private company following its merger.
Risk Assessment
Risk Level: medium — The merger and subsequent delisting represent a significant change in the company's structure and public trading status, which can introduce uncertainties for former shareholders.
Key Players & Entities
- Lyra Therapeutics, Inc. (company) — Registrant
- HealthBeacon Ltd. (company) — Acquiring entity's parent
- Nasdaq Capital Market (company) — Stock exchange where Lyra was listed
- June 13, 2025 (date) — Date of the merger closing
- June 12, 2025 (date) — Date of stockholder approval for the merger
FAQ
What was the primary event reported in this 8-K filing?
The primary event reported is the closing of the merger between Lyra Therapeutics, Inc. and a subsidiary of HealthBeacon Ltd., effective June 13, 2025.
When did Lyra Therapeutics' stockholders approve the merger?
Lyra Therapeutics' stockholders approved the merger on June 12, 2025.
What is the consequence of this merger for Lyra Therapeutics' stock?
As a result of the merger, Lyra Therapeutics, Inc. will cease to be a publicly traded company, and its common stock will no longer be listed on the Nasdaq Capital Market.
What is the effective date of the merger closing?
The merger closed on June 13, 2025.
Who is the other party involved in the merger with Lyra Therapeutics?
Lyra Therapeutics, Inc. merged with a subsidiary of HealthBeacon Ltd.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Lyra Therapeutics, Inc. (LYRA).